Chicago, IL (PRWEB) June 24, 2014
The birth control safety advocates at DrugNews.net are alerting women who have taken the oral contraceptives Yaz or Yasmin of new litigation news on the site. Recent court records show there are still nearly 9,000 lawsuits pending that allege side effects from the drugs*.
DrugNews was created for patients taking popular prescription drugs, to provide the latest product recalls, safety alerts, research and litigation news. Visitors can recognize potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The resource center has added warnings from health experts such as the FDA*** and British Medical Journal**** that birth controls like Yaz and Yasmin, which contain drospirenone, can increase risks of blood clots. The U.K.’s Medicines and Healthcare Products Regulatory Agency also recently advised certain meds like Yasmin can double the risk of blood clots*****.
Due to the number of patients that have filed a Yaz lawsuit alleging side effects, cases have been consolidated in a special federal court (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
Bayer, who makes Yaz and Yasmin, has spent $1.74 billion to settle around 8,560 Yaz lawsuits already alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)**.
Now, DrugNews has learned the latest court records show there are still 8,919 Yaz cases still pending as of June 16th*. However, that number has declined over 5% in recent months, from 9,426 on April 15.
Lawyers are still helping those injured. Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is encouraged to visit DrugNews.net or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have settled hundreds of Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML, 6/16/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-June-16-2014.pdf
**Bayer 2014 Q1 Report, Explanatory Notes, Legal Risks, 4/28/14; stockholders-newsletter-q1-2014.bayer.com/en/explanatory-notes.aspx#legalrisks
***FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
****BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
*****British Journal of Family Medicine, Feb 2014; bjfm.co.uk/content/article.aspx?id=25769806997